This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 Feb;2(2):131-6.

doi: 10.1093/oxfordjournals.annonc.a057876.

Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma

J R Hardy¹, E Wiltshaw, P R Blake, P Harper, M Slevin, T J Perren, S Tan

Affiliations

PMID: 2054315
DOI: 10.1093/oxfordjournals.annonc.a057876

Free article

Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma

J R Hardy et al. Ann Oncol. 1991 Feb.

Free article

. 1991 Feb;2(2):131-6.

doi: 10.1093/oxfordjournals.annonc.a057876.

Authors

J R Hardy¹, E Wiltshaw, P R Blake, P Harper, M Slevin, T J Perren, S Tan

Affiliation

¹ Gynaecologic Oncology Unit, Royal Marsden Hospital, London, U.K.

PMID: 2054315
DOI: 10.1093/oxfordjournals.annonc.a057876

No abstract available

PubMed Disclaimer

Similar articles

[Study by the Working Group in Gynecologic Oncology for therapeutic optimization in advanced FIGO IIb-IV ovarian carcinoma: cisplatin-paclitaxel vs. carboplatin-paclitaxel. AGO Protocol Ovar-3].
Mettler L. Mettler L. Zentralbl Gynakol. 1996;118(6):379-4. Zentralbl Gynakol. 1996. PMID: 8768017 Clinical Trial. German. No abstract available.
Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer.
Adachi S, Itani Y, Ito K, Noda T, Shintani M, Saito K, Furukawa N, Tomii Y. Adachi S, et al. Oncol Rep. 2001 Jan-Feb;8(1):27-31. Oncol Rep. 2001. PMID: 11115564 Clinical Trial.
Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Gray HJ, et al. Gynecol Oncol. 2010 Mar;116(3):340-4. doi: 10.1016/j.ygyno.2009.10.054. Epub 2009 Nov 17. Gynecol Oncol. 2010. PMID: 19922987
[Prognostic factors of ovarian cancer].
Ochiai K. Ochiai K. Gan To Kagaku Ryoho. 2006 Dec;33(13):2014-9. Gan To Kagaku Ryoho. 2006. PMID: 17197745 Review. Japanese.
[Drug therapy of ovarian carcinoma].
Dittrich C. Dittrich C. Wien Med Wochenschr. 1996;146(1-2):23-34. Wien Med Wochenschr. 1996. PMID: 8835492 Review. German.

See all similar articles

Cited by

Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A, Hiu S, Kunonga PT, Gajjar K, Craig D, Vale L, Winter-Roach BA, Elattar A, Naik R. Bryant A, et al. Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.
Planting AS, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Br J Cancer. 1993 Oct;68(4):789-92. doi: 10.1038/bjc.1993.429. Br J Cancer. 1993. PMID: 8398709 Free PMC article. Clinical Trial.
Principles and Innovations in Peritoneal Surface Malignancy Treatment.
MacArthur KM, Nicholl MB. MacArthur KM, et al. World J Oncol. 2013 Jun;4(3):129-136. doi: 10.4021/wjon660w. Epub 2013 Jul 15. World J Oncol. 2013. PMID: 29147344 Free PMC article. Review.
Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Elattar A, et al. Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Cochrane Database Syst Rev. 2011. PMID: 21833960 Free PMC article.
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Glockzin G, Schlitt HJ, Piso P. Glockzin G, et al. World J Surg Oncol. 2009 Jan 8;7:5. doi: 10.1186/1477-7819-7-5. World J Surg Oncol. 2009. PMID: 19133112 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information